Linagliptin: Farmacology, Efficacy and Safety in Type 2 Diabetes Treatment

Diabetology and Metabolic Syndrome- United Kingdom

doi 10.1186/1758-5996-5-25

Full Text

Abstract

Available in

Categories

Internal Medicine

Date

May 22, 2013

Authors

Erika Paniago Guedes

Thais Gomes de Melo

Publisher

Springer Science and Business Media LLC

Related search

Linagliptin Treatment Improves Cerebrovascular Function and Remodeling and Restores Reduced Cerebral Perfusion in Type 2 Diabetes

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

English

Efficacy and Safety of Imarikiren in Patients With Type 2 Diabetes and Microalbuminuria

Clinical Journal of the American Society of Nephrology

Transplantation

Intensive Care Medicine

English

Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes With Microalbuminuria

Clinical Journal of the American Society of Nephrology

Transplantation

Intensive Care Medicine

English

Efficacy and Safety of Jentadueto® (Linagliptin Plus Metformin)

Expert Opinion on Drug Safety

English

Emerging DPP-4 Inhibitors: Focus on Linagliptin for Type 2 Diabetes

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

Internal Medicine

English

Efficacy and Safety of Repaglinide vs Nateglinide for Treatment of Japanese Patients With Type 2 Diabetes Mellitus

Journal of Diabetes Investigation

Internal Medicine

English

Linagliptin Increases Incretin Levels, Lowers Glucagon, and Improves Glycemic Control in Type 2 Diabetes Mellitus

Diabetes Therapy

Internal Medicine

English

Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: A Systematic Review and Mixed-Treatment Comparison Analysis

Diabetes, Obesity and Metabolism

Internal Medicine

English

Glycemic Treatment in Type 1 and Type 2 Diabetes

Internal Medicine

Specialized Nursing

English